Social isolation: A serious but under-recognized health risk
By
Cathy Lipton, MD
Jul 28, 2022
How senior living communities can build on pandemic lessons to reduce loneliness.
Virtual community of long-term care and other providers commits to ‘age-friendly’ care guidelines
By
Aaron Dorman
Nov 03, 2023
Recruiting has begun for providers for the fifth iteration of an ‘age friendly’ network who will have access to webinars, coaching and more.
Gamma for Grandma? Brain rhythm stimulation could beat current long-term strategy for Alzheimer’s,...
By
Aaron Dorman
Dec 21, 2023
A range of “multisensory and noninvasive” interventions can be used to induce gamma stimulation in the brain, a new study indicates.
Therapy robot helps ease dementia symptoms: study
By
Lois A. Bowers
Mar 31, 2016
A robotic pet can be effective in decreasing wandering and anxiety-related behaviors in memory care residents, according to the results of a six-month study in seven Front Porch retirement communities...
Digital tool for helping caregivers of dementia patients gets $3.5 million grant
By
Aaron Dorman
Jan 04, 2024
University researchers are testing a new digital tool that has been designed to help caregivers of people living with dementia.
Review of light therapy studies confirms its potential for helping Alzheimer’s patients
By
Aaron Dorman
Dec 08, 2023
A review of recent literature on light therapy reiterated that it improved sleep and behavior issues for those living with Alzheimer’s disease.
Focus On briefs: Resident security
Jun 06, 2022
HealthPRO Heritage adds enterprise partnership service; Dementia residents in LTC suffered outsized pandemic mortality spikes; AI could shape future rehab therapy
Sensitivity study shines a light on how Alzheimer’s patients could benefit from carefully managed sleep...
By
Aaron Dorman
Aug 01, 2023
Light therapy could be a vital tool for people living with Alzheimer’s to manage or slow the disease, a new study shows.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.